home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/183896f1-ed1f-4005-a462-df6349b93fb7_biomedtracker-catalyst-roundup-2018-q4.pdf
infographic
SHARESHARESHARE
BIOMEDTRACKER: CATALYST ROUNDUP 2018 Q4
This vital infographic contains critical data about catalysts for AEVI-001 for Attention Deficit Hyperactivity Disorder (ADHD) (Aevi Genomic Medicine, Inc. (GNMX)), and SAGE-217 for Major Depressive Disorder (MDD), (SAGE Therapeutics (SAGE)), including: Don’t miss this free resource from the leader in providing objective information alongside evidence-based clinical assessments and investment research on pipeline drugs worldwide. Download the Catalyst Roundup from Biomedtracker today. DOWNLOAD